Evaluation of Surgical and Aesthetic Outcomes of Goldilocks Mastectomy for Breast Cancer in Females | ||||
Zagazig University Medical Journal | ||||
Volume 31, Issue 8, August 2025, Page 4218-4226 PDF (1.17 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/zumj.2025.384703.3951 | ||||
![]() | ||||
Authors | ||||
Mohamed Hosam Habashy ![]() ![]() | ||||
1Department of General Surgery, Faculty of Medicine, Zagazig university, Egypt | ||||
2Professor of General surgery department, Faculty of Medicine, Zagazig University, Egypt | ||||
3Associate Professor of General surgery department, Faculty of Medicine, Zagazig University, Egypt | ||||
4Lecturer of Plastic & reconstructive Surgery department, Faculty of Medicine, Zagazig University, Egypt | ||||
5Lecturer of General surgery department, Faculty of Medicine, Zagazig University, Egypt | ||||
Abstract | ||||
Background: For women with breast cancer, a skin-sparing mastectomy has been found to be an oncologically safe choice. The Goldilocks mastectomy method was first used in 2012. The extra tissue in the breast's lower region is used in this surgery. The purpose of this study was to determine the Goldilocks mastectomy procedure's aesthetic results and complications, as well as to evaluate the procedure's viability in patients with breast cancer. Methods: This was a prospective single-arm clinical study which was conducted from April 2024 to February 2025 at the Surgical Oncology Unit of General Surgery Department at Zagazig University Hospitals over 24 eligible female patients, diagnosed with breast cancer and candidate to undergo Goldilocks mastectomy procedure. Clinical data was collected regarding symptoms, laboratory investigations and radiology investigations. Results: Seven patients (29.2%) had a positive family history, two patients (8.3%) had received neoadjuvant chemotherapy, and the mean age was 43.8 years. 18 patients (75%) had invasive ductal carcinoma (IDC), four patients (16.6%) had invasive lobular carcinoma (ILC), one patient (4.2%) had multifocal carcinoma in situ, and one patient (4.2%) had multi-centric carcinoma in situ, according to sonomammography and histopathological analysis. The rate of complications was 12.5% overall. Regarding sexual well-being, there was a significantly significant difference (P<0.001) between the preoperative and postoperative breast-Q assessments. Conclusion: For female patients with breast cancer who have macromastia and/or severe breast ptosis, a Goldilocks mastectomy is a viable choice. | ||||
Keywords | ||||
Breast cancer; Goldilocks mastectomy; Wise pattern | ||||
Statistics Article View: 42,996 PDF Download: 27 |
||||